About UsProductsInvestor RelationsPress ReleasesContact Us
August 12, 2014

Merus Labs International Inc. Announces Third Quarter Results for Fiscal 2014
August 7, 2014

Merus Labs International Inc. Subsidiary Signs Product Acquisition Letter of Intent
July 17, 2014

Merus Labs International Inc. Announces Conversion of $10 Million Convertible Debentures
July 11, 2014

Merus Labs International Inc. Announces Closing of $10 Million Preferred Share Financing
July 4, 2014

Merus Signs Definitive Acquisition Agreement with Dacha Strategic Metals Inc.
ENABLEX®/ EMSELEX®
Enablex® (darifenacin) is a prescription medicine used in adults to treat the following symptoms of overactive bladder: a strong need to urinate with leaking or wetting accidents (urge urinary incontinence), a strong need to urinate right away (urgency), and having to urinate often (urinary frequency)... [more]
VANCOCIN® capsules
Clostridium difficile infection (CDI) causes watery or mucousy diarrhea, lower abdominal pain and systemic symptoms such as fever, anorexia, nausea and malaise when mildly symptomatic, and life-threatening toxic megacolon when severe... [more]

Symbol: MSLI
Last:
Change:
Date:
Time:
Symbol: MSL
Last:
Change:
Date:
Time:
Quotes are delayed at least 15 minutes.
Get latest news from Merus Labs via e-mail.
Subscribe
Unsubscribe
Submit

Copyright © 2012 Merus Labs Inc. All Rights Reserved.